Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31,604,526
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
38,712,156
-
Shares change
-
-496,020
-
Total reported value, excl. options
-
$865,246,259
-
Value change
-
-$10,117,275
-
Number of buys
-
91
-
Number of sells
-
-78
-
Price
-
$22.35
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q3 2023
197 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q3 2023.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,712,156 shares
.
Largest 10 shareholders include BlackRock Inc. (6,240,964 shares), Rubric Capital Management LP (3,175,000 shares), EVENTIDE ASSET MANAGEMENT, LLC (2,631,334 shares), VANGUARD GROUP INC (2,339,096 shares), PRINCIPAL FINANCIAL GROUP INC (1,579,240 shares), Pacer Advisors, Inc. (1,291,338 shares), STATE STREET CORP (1,290,496 shares), RENAISSANCE TECHNOLOGIES LLC (1,172,598 shares), Invesco Ltd. (1,159,604 shares), and Camber Capital Management LP (1,050,000 shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.